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OBJECTIVE — Individuals with type 2 diabetes have high risk of late-life cognitive impair-
ment,yetlittleisknownaboutstrategiestomodifyrisk.Targetinginsulinresistanceandvascular
complications—both associated with cognitive decline—may be a productive approach. We
investigatedwhetherdietaryfat,whichmodulatesglucoseandlipidmetabolism,mightinﬂuence
cognitive decline in older adults with diabetes.
RESEARCH DESIGN AND METHODS — Beginning in 1995–1999, we evaluated cog-
nitivefunctionin1,486Nurses’HealthStudyparticipants,aged70years,withtype2diabetes;
second evaluations were conducted 2 years later. Dietary fat intake was assessed regularly
beginningin1980;weconsideredaverageintakefrom1980(atmidlife)throughinitialcognitive
interview and also after diabetes diagnosis. We used multivariate-adjusted linear regression
models to obtain mean differences in cognitive decline across tertiles of fat intake.
RESULTS — Higher intakes of saturated and trans fat since midlife, and lower polyunsatu-
rated to saturated fat ratio, were each highly associated with worse cognitive decline in these
women. On a global score averaging all six cognitive tests, mean decline among women in the
highest trans fat tertile was 0.15 standard units worse than that among women in the lowest
tertile (95% CI 0.24 to 0.06, P  0.002); this mean difference was comparable with the
differenceweﬁndinwomen7yearsapartinage.Resultsweresimilarwhenweanalyzeddietafter
diabetes diagnosis.
CONCLUSIONS — These ﬁndings suggest that lower intakes of saturated and trans fat and
higher intake of polyunsaturated fat relative to saturated fat may reduce cognitive decline in
individuals with type 2 diabetes.
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T
ype2diabeteshasreachedepidemic
proportions in most Western coun-
tries, including 20 million individu-
alsaffectedintheU.S.(1).Cardiovascular
disease, kidney failure, and neuropathy
are known sequelae, but cognitive im-
pairment is increasingly recognized as a
further complication at older ages (2).
Therefore, identifying strategies to pre-
vent or delay diabetes-related cognitive
impairment is a growing public health
concern. Dietary fat intake can alter glu-
cose and lipid metabolism (3) and is re-
lated to cardiovascular disease risk in
individuals with type 2 diabetes (4). Be-
cause insulin, cholesterol, and vascular
disease all appear to play important roles
in brain aging and cognitive impairments
(5), dietary fat modiﬁcation may be a par-
ticularly effective strategy for preventing
cognitive decline, especially in individu-
als with diabetes. Thus, we studied nearly
1,500 Nurses’ Health Study participants
with type 2 diabetes to evaluate the rela-
tion between dietary fat intake and subse-
quent cognitive decline.
RESEARCH DESIGN AND
METHODS— The Nurses’ Health
Study began in 1976, when 121,700 reg-
istered nurses, aged 30–55 years, com-
pleted a mailed questionnaire about their
health and lifestyle, including type 2 diabe-
tes. Follow-up questionnaires are mailed
every 2 years, and a food-frequency ques-
tionnaire was added in 1980. All self-
reported diabetes case subjects were sent
a supplemental questionnaire to ascertain
symptoms, diagnostic tests, and treat-
ment; standard criteria were used to con-
ﬁrmtype2diabetes.Inavalidationstudy,
we found that medical record review cor-
roborated 98% of self-reported diabetes
cases (6). Furthermore, in a random sam-
ple of participants who reported no diag-
nosis of diabetes, 2% had diagnostic
evidence of diabetes in blood tests (7);
this suggests that underreporting or un-
derdiagnosis of diabetes is likely minimal
in this population of health professionals
withgoodhealthknowledgeandaccessto
health care.
Starting in 1995–1999, Nurses’
HealthStudyparticipantsaged70years
were selected for a study of cognitive
function; the ﬁrst years were largely pilot
interviews, and the vast majority of base-
line data were collected in 1998–1999. A
telephone interview was conducted in
community-dwelling women who were
freeofstroke;93%ofeligiblewomenpar-
ticipated (n  19,415) and 7% refused.
Follow-upinterviewswereconducted2
years later (mean 1.8 years, range 1.3–
4.7), and participation rates were 90%
for women who were still alive. Prelimi-
nary data are also available from an addi-
tional follow-up assessment (mean
follow-up4.2years).TheInstitutionalRe-
view Board of Brigham and Women’s
Hospital (Boston, MA) approved this
study. For questionnaire information, re-
turn of the questionnaire implied in-
formed consent, and we obtained oral
consent for the cognitive study.
Dietary assessment
We used a Willett semiquantitative food
frequency questionnaire (8) to assess di-
etary habits in 1980, 1984, 1986, and ev-
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speciﬁed using a common unit or portion
size (e.g., one slice of bread or one 8-oz
glass of milk), and detailed information
was collected on type of fat or oil used in
food preparation. Women reported how
oftenonaveragetheyhadconsumedeach
item during the previous year, with nine
response categories ranging from “almost
never” to “six or more times per day.” For
each food, the reported frequency of con-
sumption was multiplied by its nutrient
content (speciﬁed in the Harvard Univer-
sity Food Composition Database and up-
dated regularly). Fat intakes were then
summed across all food sources and con-
verted to nutrient densities, reﬂecting in-
take as a percentage of total energy
consumed.Weconsideredthefollowingfat
types: saturated, monounsaturated, poly-
unsaturated, trans-unsaturated, and the
ratio of polyunsaturated to saturated fat.
In a validation study (9), we deter-
mined that dietary fat intake was ascer-
tained reasonably well compared to four
1-week dietary records collected over 1
year.Forexample,correlationcoefﬁcients
between the two methods were 0.59 for
saturated fat, 0.48 for polyunsaturated
fat, and 0.53 for total fat. For trans fat, the
correlation between our values and trans
fatcompositioninadiposetissuewas0.51
(10).
Population for analysis
For this study, we excluded women who
did not report dietary information on the
initial food frequency questionnaire in
1980 (n  330). We analyzed 1,486 re-
mainingwomenwithtype2diabetesasof
their initial cognitive assessment. The
subset of women we excluded was com-
parable to the study population; for ex-
ample, their mean age was identical (74.3
years) and average BMI was very similar
(28.8 vs. 29.2 kg/m
2).
Cognitive assessment
Initially, we administered the Telephone
InterviewofCognitiveStatus,atelephone
adaptation of the Mini-Mental State Ex-
amination, which is highly correlated to
the Mini-Mental State Examination (r 
0.94) (11). After high participation rates
were established, we gradually added ﬁve
other tests: East Boston Memory Test–
immediate and delayed recalls (12), cate-
goryﬂuency(13,14),delayedrecallof10-
word list, and digit span backward (15).
Trained nurses administered the cogni-
tive interview and were unaware of par-
ticipants’ dietary fat intake. Inter-
interviewer reliability was high across 10
interviewers (r  0.95 for each cognitive
test). In a validation study, our cognitive
battery was administered to 61 highly ed-
ucated women and correlated well with
detailed in-person interviews (r  0.81).
Finally, participation rates were identical
across all cognitive tests and remained
stable over time.
Our analyses focused on measures of
global cognition and verbal memory. For
global cognition, we averaged together all
six cognitive tests. Because a point on
each test is not equivalent, we created z
scores by taking the difference between
each participant’s score and the popula-
tion mean score and dividing by the pop-
ulation SD. For verbal memory (a strong
predictor of developing Alzheimer’s dis-
ease [16–18]), we averaged together four
tests:immediateanddelayedrecallsofthe
East Boston Memory Test and Telephone
Interview of Cognitive Status 10-word
list. Both composite scores were con-
structed only for women who completed
all contributing tests.
Statistical analysis
Because pathology underlying both dia-
betes and cognitive decline is likely initi-
ated many years before clinical disease,
dietary habits since midlife may be most
important(19);thus,ourprimarypredic-
torwasfatintakesincemidlife,calculated
as the average reported from 1980
throughthelastdietaryassessmentbefore
initial cognitive interview. However, to
speciﬁcallyconsiderdietafterdiabetesdi-
agnosis,especiallysincewomenmayhave
changed their diet in response to the di-
agnosis, we separately averaged fat intake
beginning after diabetes diagnosis.
Multivariate-adjusted linear regres-
sion models were used to obtain mean
differencesincognitivedeclineacrosster-
tiles of fat intake. The 95% CIs were cal-
culated, and linear trend tests were
performedusingthemedianvalueofeach
tertile. We considered many potential
confounders: age, education, depression
(based on self-reported use of antidepres-
sant medication), vitamin E supplement
use, alcohol intake, physical activity
(based on a validated physical activity
questionnaire), smoking status, use of
cholesterol-lowering medications, and
history of high blood pressure, high cho-
lesterol, or myocardial infarction.
Of these, we retained age, education,
and physical activity because their inclu-
sion changed effect estimates by 10%.
Additionally, in all models, we adjusted
forindicatorsofdiabetesseveritythathad
particular potential to confound our re-
sults (BMI, disease duration, and treat-
ment). We also included baseline
cognitive score, time between cognitive
interviews, and total caloric intake in
models, as well as each type of dietary fat
and cholesterol intake. These covariates
were derived from participants’ status at
the time of initial cognitive assessment
(except dietary covariates, which are cu-
mulative averages). In a small subset of
women (n  404) with information avail-
able, we further adjusted for A1C levels
reported near the time of initial cognitive
interview.
In addition, because reducing one
type of fat without substituting another is
difﬁcult, we additionally evaluated “sub-
stitution” models that included continu-
ous terms for intakes of “good” fat (the
total of mono- and polyunsaturated fat),
“bad” fat (the total of saturated and trans
fat), cholesterol, and protein. By exclud-
ing carbohydrates from the model, we
could interpret the results as the effect of
replacing 1% of energy from carbohy-
drates with an equivalent percentage of
energy from the fat group of interest. We
subtracted model coefﬁcients for “good
fat”and“badfat”todeterminetheeffectof
replacing one type of fat with the other.
Finally,wehadpreliminarydatafrom
a third cognitive interview; however, the
trajectory of cognitive decline across the
three interviews was nonlinear (because of
an expected learning effect between the
ﬁrst and second interviews). Therefore,
these data were more complex to model.
In these preliminary analyses, we used
general linear models of response proﬁles
and modeling time with indicator vari-
ables for assessment rather than with a
linear variable. These models are more
difﬁculttointerpretandarelesspowerful,
since associations are estimated for each
data collection point separately, rather
than estimated linearly over time. All
analyses were performed in SAS, version
9, software (Cary, NC).
RESULTS— On average, women com-
pleted ﬁve dietary assessments during the
analysis period and three assessments af-
ter diabetes diagnosis. We observed few
meaningful differences in health and life-
style across tertiles of several major fat
types, with intake averaged since midlife
(Table 1). However, women with higher
intakes of saturated and trans fat were
slightly less likely to take vitamin E sup-
plements and had slightly higher preva-
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Women with higher saturated fat intake
were also somewhat less likely to exercise
and have a history of hypercholesterolemia
(womenwithhighcholesterolmayhaveini-
tiateddietarychanges).Inaddition,women
in increasing tertiles of polyunsaturated fat
intake were somewhat more likely to use
vitamin E supplements.
For diet since midlife, we found sig-
niﬁcantly worse cognitive decline on the
globalscorewithincreasingintakesofsat-
urated (P trend  0.02) and trans fat (P
trend  0.002) (Table 2). For example,
women in the highest tertile of trans fat
intake had a mean decline in the global
score that was 0.15 standard units (95%
CI 0.24 to 0.06) worse than those in
the lowest tertile, after multivariable ad-
justment for age, education, BMI, physi-
cal activity, and measures of diabetes
severity. Results were virtually identical
with further adjustment for depression,
vitaminEsupplementuse,alcoholintake,
smoking status, and history of high blood
pressure, high cholesterol, or myocardial
infarction (mean difference in decline 
0.16 standard units; 95% CI 0.25 to
0.07, comparing extreme tertiles of
trans fat) (data not shown in Table 2). For
saturated fat, the mean difference in
global decline was 0.12 standard units
(95% CI 0.22 to 0.01) comparing top
and bottom tertiles. To help interpret
theseresults,wecomparedtheseeffectes-
timates to those we found for the relation
of age to cognitive decline in our popula-
tion. We found that a 1-year age increase
was associated with a mean global score
Table 1—Characteristics of women at initial cognitive assessment, by tertile of dietary fat intake since midlife
Saturated fat Polyunsaturated fat Trans fat
Tertile 1 Tertile 2 Tertile 3 Tertile 1 Tertile 2 Tertile 3 Tertile 1 Tertile 2 Tertile 3
Mean age (years) 75 74 74 74 74 74 75 74 74
Education (% registered nurse degree) 78 78 82 78 82 79 76 81 82
Antidepressant use (%) 867776786
Vitamin E supplements (%) 53 50 41 44 49 52 55 48 42
No alcohol intake (%) 68 68 74 70 70 70 68 67 76
BMI 30 kg/m
2 (%) 33 39 40 35 38 39 34 37 41
Former smokers (%) 48 46 47 47 48 46 51 48 42
Current smokers (%) 367655457
Median physical activity (METs per week*) 854566765
History of high blood pressure (%) 78 74 79 78 76 77 75 78 77
History of high cholesterol (%) 81 78 69 77 76 76 79 76 74
History of myocardial infarction (%) 16 15 12 16 15 12 16 16 11
Median diabetes duration (years) 10 8 9 10 9 9 10 9 8
Oral hypoglycemic use (%) 30 34 37 32 34 35 32 36 33
Insulin use (%) 14 14 16 17 13 14 16 15 13
Percentages are of nonmissing values. Average diet intake since midlife from 1980 through the initial cognitive interview. *One metabolic equivalent hour (MET)
is proportional to the amount of energy expended sitting quietly.
Table 2—Mean differences in change in cognitive function scores, by tertile of dietary fat intake since midlife
Tertile 1 Tertile 2 Tertile 3 Ptrend
Saturated fat (median intake)* 9.8 11.5 13.5
Global score 0.00 (ref) 0.006 (0.09 to 0.08) 0.12 (0.22 to 0.01) 0.02
Verbal score 0.00 (ref) 0.02 (0.12 to 0.09) 0.09 (0.22 to 0.05) 0.2
Monounsaturated fat (median intake)* 10.6 12.6 14.6
Global score 0.00 (ref) 0.10 (0.01 to 0.19) 0.12 (0.002 to 0.24) 0.06
Verbal score 0.00 (ref) 0.06 (0.05 to 0.17) 0.08 (0.07 to 0.23) 0.3
Polyunsaturated fat (median intake)* 4.7 5.6 6.7
Global score 0.00 (ref) 0.03 (0.04 to 0.11) 0.03 (0.06 to 0.11) 0.5
Verbal score 0.00 (ref) 0.02 (0.08 to 0.11) 0.02 (0.09 to 0.13) 0.7
Trans fat (median intake)* 1.2 1.6 2.0
Global score 0.00 (ref) 0.09 (0.17 to 0.01) 0.15 (0.24 to 0.06) 0.002
Verbal score 0.00 (ref) 0.10 (0.20 to 0.0002) 0.15 (0.27 to 0.03) 0.01
Ratio of polyunsaturated to saturated fat (median intake) 0.4 0.5 0.6
Global score 0.00 (ref) 0.04 (0.03 to 0.11) 0.08 (0.008 to 0.16) 0.03
Verbal score 0.00 (ref) 0.04 (0.05 to 0.14) 0.07 (0.03 to 0.16) 0.2
Data are mean differences (95% CI) unless otherwise indicated. Average diet intake since midlife from 1980 through the initial cognitive interview. Models are
adjusted for age (continuous), education (registered nurse, bachelor’s, or graduate degree), other fats and cholesterol (in tertiles), total caloric intake (continuous),
baseline cognition (continuous), time between cognitive interviews (continuous), BMI (continuous), physical activity (continuous), diabetes medication (none, oral
hypoglycemic medication only, insulin use), and duration of diabetes (5, 5–9, 10–14, and 15 years). *Fat intake is expressed as a percentage of total energy
consumption.
Devore and Associates
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association we observed for high con-
sumption of trans fat was equivalent to
7 years of cognitive aging, and the ob-
served relation for high saturated fat in-
takewasequivalentto6yearsofcognitive
aging.
In contrast, women with higher in-
take of monounsaturated fat maintained
better cognitive function than those with
lower intake, although this ﬁnding was
only borderline signiﬁcant (P trend 
0.06). Polyunsaturated fat intake, consid-
ered alone, was not signiﬁcantly associ-
ated with cognitive decline (P trend 
0.5); however, women with a higher ratio
of polyunsaturated to saturated fat intake
had signiﬁcantly lower rates of cognitive
decline for the global score (P trend 
0.03). Speciﬁcally, compared with
women in the lowest tertile of polyunsat-
urated fat relative to saturated fat intake,
those in the highest tertile declined an av-
erage of 0.08 standard units less (95% CI
0.008–0.16).
In secondary analyses, results were
not substantially different when we ad-
justed for A1C levels, although P values
were higher in the small subset of women
with this information. For example, the
mean difference in global score was
0.12 standard units before adjustment
for A1C versus 0.11 after adjustment,
when extreme tertiles of saturated fat
were compared.
Substitution models yielded results
that were consistent with those given
above (data not shown in Table 2); spe-
ciﬁcally, replacement of 1% of total en-
ergy from “bad” fat (saturated and trans
unsaturated) with the same percentage of
energy from “good” fat (mono- and poly-
unsaturated) was associated with signiﬁ-
cantlylesscognitivedecline.Forexample,
fora5%substitution,themeandifference
in global score decline was 0.15 standard
units (95% CI 0.005–0.30). That is, re-
placing 5% of energy from bad fat with
good fat could be considered cognitively
equivalent to delaying aging by 7 years.
In analyses of diet after diabetes diag-
nosis, women had an average of 9 years
between diagnosis and initial cognitive
interview.Relationsofpostdiabetesfatin-
take and cognitive decline were similar to
those observed when we considered diet
since midlife (Table 3). Increasing intake
of saturated fat was related to worse cog-
nitive decline across global (P  0.003)
and verbal scores (P trend  0.02). Spe-
ciﬁcally, women in the highest tertile of
saturated fat declined an average of 0.18
standard units more in the global score
than those in the lowest tertile (95% CI
0.29 to 0.06). We also found that
women with higher intake of trans fat had
worse decline on the global score (P
trend  0.07), a ﬁnding that was border-
line signiﬁcant. As anticipated, average
trans fat intake in these analyses of more
recent diet was lower (by 19%) than in
analyses of diet since midlife. In addi-
tion, a higher polyunsaturated fat–to–
saturated fat ratio was related to better
maintenance of cognition; this relation
was also borderline signiﬁcant (P trend 
0.08). Finally, results were similar in
modelsthatsimultaneouslyincludedsep-
arate terms for fat intake before and after
diabetes diagnosis, indicating that diet
couldbeequallyimportantduringthepe-
riod before and after clinical diagnosis of
diabetes.
In preliminary analyses of decline
over three cognitive assessments, we
found results consistent with those re-
portedabove.Greaterintakesofsaturated
and trans fat were associated with worse
cognitive decline for both global and ver-
bal scores, although not all trends were
statisticallysigniﬁcant(e.g.,fortransfat,P
trend  0.2 for the global score and P
trend  0.05 for the verbal score).
CONCLUSIONS — In women with
type 2 diabetes, we found that higher in-
takes of saturated and trans fat were re-
lated to substantially worse cognitive
decline. Furthermore, substitution of sat-
urated and trans fat with mono- or poly-
unsaturated fat was associated with less
cognitive decline. The magnitude of these
results was considerable, and the associa-
tions we observed were equivalent to the
cognitive effects we ﬁnd for 6–7 years of
aging in these women. Importantly, these
relations were similar before and after di-
abetes diagnosis; this is consistent with
the pathogenesis of both diabetes and
cognitive decline, including well-
recognized pre-diabetic changes in insu-
Table 3—Mean differences in change in cognitive function scores, by tertile of dietary fat intake after diabetes diagnosis
Tertile 1 Tertile 2 Tertile 3 Ptrend
Saturated fat (median intake)* 7.7 10.1 12.5
Global score 0.00 (ref) 0.09 (0.18 to 0.0006) 0.18 (0.29 to 0.06) 0.003
Verbal score 0.00 (ref) 0.11 (0.22 to 0.005) 0.18 (0.33 to 0.03) 0.02
Monounsaturated fat (median intake)* 9.2 11.6 14.1
Global score 0.00 (ref) 0.06 (0.03 to 0.15) 0.09 (0.03 to 0.20) 0.2
Verbal score 0.00 (ref) 0.05 (0.06 to 0.16) 0.07 (0.07 to 0.21) 0.4
Polyunsaturated fat (median intake)* 4.4 5.5 6.8
Global score 0.00 (ref) 0.06 (0.02 to 0.14) 0.04 (0.04 to 0.13) 0.3
Verbal score 0.00 (ref) 0.06 (0.04 to 0.15) 0.03 (0.08 to 0.14) 0.6
Trans fat (median intake)* 0.9 1.3 1.7
Global score 0.00 (ref) 0.07 (0.16 to 0.01) 0.10 (0.20 to 0.007) 0.07
Verbal score 0.00 (ref) 0.09 (0.20 to 0.01) 0.08 (0.21 to 0.05) 0.2
Ratio of polyunsaturated to saturated fat (median intake) 0.4 0.6 0.8
Global score 0.00 (ref) 0.05 (0.03 to 0.13) 0.07 (0.008 to 0.16) 0.08
Verbal score 0.00 (ref) 0.02 (0.08 to 0.12) 0.06 (0.04 to 0.17) 0.2
Data are mean differences (95% CI) unless otherwise indicated. Average diet intake after diabetes diagnosis from diabetes diagnosis through the initial cognitive
interview. Models are adjusted for age (continuous), education (registered nurse, bachelor’s, or graduate degree), other fats and cholesterol (in tertiles), total caloric
intake (continuous), baseline cognition (continuous), time between cognitive interviews (continuous), BMI (continuous), physical activity (continuous), diabetes
medication (none, oral hypoglycemic medication only, insulin use), and duration of diabetes (5, 5–9, 10–14, and 15 years). *Fat intake is expressed as a
percentage of total energy consumption.
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preclinical phase associated with cognitive
decline. To our knowledge, this is the ﬁrst
large-scaleprospectivestudytoexaminedi-
etary fat intake in relation to cognitive de-
cline among type 2 diabetic subjects.
Limitedpreviousstudieshaveyielded
inconsistent results on the association of
dietary fat intake and cognitive decline in
healthy subjects (20), but several lines of
evidence suggest that dietary fat modiﬁ-
cation may have a more compelling ratio-
naleindiabeticsubjects.Higherintakesof
saturated and trans fat and lower intakes
of mono- and polyunsaturated fat can
contribute to insulin resistance and an
atherogenic lipid proﬁle (21). Moreover,
insulin resistance, high insulin levels,
and cholesterol are all implicated in
-amyloid accumulation in the brain—
the pathologic hallmark of Alzheimer’s
disease (22). In type 2 diabetic subjects,
replacementofsaturatedfatwithmono-
unsaturated fat is associated with im-
provements in glucose and lipid
metabolism (23), and higher intake of
saturated fat, or lower intake of polyun-
saturated fat relative to saturated fat, el-
evates the risk of cardiovascular disease
(4)—a condition that has been consis-
tentlylinkedtoanincreasedriskofcog-
nitive decline (24).
This study has several limitations.
First, self-reported dietary information
can lead to random misclassiﬁcation and
underestimation of associations in a pro-
spective study. However, we averaged re-
peated dietary measures, which decreases
random error. Differential bias may have
occurredifthediagnosisofdiabetesledto
dietary changes; however, our results
were similar for pre- and post-diabetes fat
intake, including models with simulta-
neous adjustment for these intake peri-
ods. Additional adjustment for several
comorbidconditionscommonindiabetic
subjects (which could also be confound-
ingvariablesrelatedtodietaryhabits)also
did not change our results. Furthermore,
if subjects with poorer health or more co-
morbid conditions were most motivated
to adopt better dietary habits, this would
tend to bias our results toward the null
and would not explain the strong rela-
tions we found between fat intake and
cognition.
Most importantly, this was an obser-
vational study, and therefore we cannot
rule out the possibility of confounding.
However, we found robust results over
long follow-up periods and considered
confounding by a wide range of health
and lifestyle factors. We studied a homo-
geneous cohort of well-educated female
health professionals, which minimizes
confounding by health knowledge and
access to health care. Still, confounding
bydiabetesseverityandcontrolremainsa
possible concern. Although we do not
have information on diabetes control
from all women, we used key proxy mea-
sures—diabetesmedicationandduration
of diabetes—since they are likely impor-
tant indicators of disease status and both
have been associated with cognitive func-
tion (25). In a small subset of women, we
had information on A1C levels available
as part of other research in the Nurses’
Health Study. First, we found a very
strong relation between these A1C levels
and use of diabetes medications (data not
shown), suggesting that adjustment for
self-reported use of diabetic medications
may provide reasonable adjustment for
disease severity. Moreover, in a small
sample of these women, adjustment for
A1C status did not affect the relations we
observed between dietary fat and cogni-
tive decline. Nonetheless, confounding
cannot be ruled out in an observational
study, and our results should be inter-
preted with caution.
In conclusion, we found that higher
long-term intakes of saturated and trans
fat were associated with substantially
worse cognitive decline in women with
type 2 diabetes, but substituting mono- or
polyunsaturated fat for these fats was re-
lated to reduced cognitive decline. Further
researchisneededtoconﬁrmtheseﬁndings
and explore additional strategies for main-
taining cognitive health in diabetics—
especially in women, who have a higher
lifetime prevalence of both type 2 diabetes
and cognitive impairments than men.
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